M

Mangoceuticals Inc
NASDAQ:MGRX

Watchlist Manager
Mangoceuticals Inc
NASDAQ:MGRX
Watchlist
Price: 0.869 USD 4.83% Market Closed
Market Cap: 12.1m USD

MGRX's latest stock split occurred on Oct 16, 2024

The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.

Before the split, MGRX traded at 0.177 per share. Afterward, the share price was about 2.47.

The adjusted shares began trading on Oct 16, 2024. This was the only stock split in MGRX's history.

Last Splits:
Oct 16, 2024
1-for-15
Pre-Split Price
2.655 0.177
Post-Split Price
2.47
Before
After
Last Splits:
Oct 16, 2024
1-for-15

Mangoceuticals Inc
Stock Splits History

MGRX Stock Splits Timeline
Oct 16, 2024
Oct 16, 2024
Split 1-for-15
/0.066666666666667
Pre-Split Price
2.655 0.177
Post-Split Price
2.47
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.1377 0.1377 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.57 8.57 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 7, 2026
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
1-for-10
/10
0.35 0.35 EUR N/A
Load More

Mangoceuticals Inc
Glance View

Market Cap
12.1m USD
Industry
Retail

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

MGRX Intrinsic Value
0.034 USD
Overvaluation 96%
Intrinsic Value
Price
M
Back to Top